+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiovascular Implants Market - Global Forecast 2026-2032- Product Image
Cardiovascular Implants Market - Global Forecast 2026-2032- Product Image
Sale

Cardiovascular Implants Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010720
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiovascular Implants Market is projected to reach USD 39.78 Billion in 2026. It is expected to continue growing at a CAGR of 6.37%, reaching USD 57.98 Billion by 2032.

Cardiovascular implants are central to modern cardiac and vascular care, spanning coronary and peripheral stents, prosthetic heart valves, pacemakers, implantable cardioverter-defibrillators, cardiac resynchronization systems, ventricular assist devices, vascular grafts, occlusion devices, and implantable monitoring technologies. Demand is anchored in a durable clinical need: the World Health Organization identifies cardiovascular disease as the leading cause of death worldwide, responsible for an estimated 17.9 million deaths annually.

Momentum in cardiovascular implants is being shaped by aging populations, rising hypertension and diabetes prevalence, improved survival after cardiac events, and broader access to minimally invasive procedures. For manufacturers, providers, and investors, the cardiovascular implants ecosystem is increasingly defined by clinical evidence, device durability, regulatory quality, digital connectivity, and the ability to demonstrate measurable improvements in patient outcomes and total cost of care.

Transformative Shifts in the Cardiovascular Implants Landscape

The cardiovascular implants landscape is shifting from open surgical intervention toward less invasive, image-guided, and catheter-based therapies. Transcatheter aortic valve replacement, drug-eluting stents, left atrial appendage closure, leadless pacing, and next-generation cardiac rhythm management platforms are expanding treatment options for older and higher-risk patients who may not be ideal candidates for conventional surgery.

At the same time, regulatory and commercial expectations are becoming more rigorous. Europe’s Medical Device Regulation has raised evidence and post-market surveillance requirements, while the U.S. Food and Drug Administration continues to emphasize safety, cybersecurity, real-world evidence, and human factors in connected medical devices. Competitive advantage is moving toward organizations that combine proven clinical performance with connected follow-up, supply chain resilience, physician training, and value-based reimbursement support.

Cumulative Impact of Artificial Intelligence on Cardiovascular Implants

Artificial intelligence is becoming an important enabler across the cardiovascular implants value chain. In clinical workflows, AI supports imaging interpretation, anatomical sizing, procedural planning, risk stratification, and remote monitoring of implanted cardiac devices. These applications are particularly relevant in electrophysiology, structural heart interventions, and heart failure management, where continuous data and precise patient selection can influence outcomes.

The cumulative impact of AI is strongest where algorithms are validated against diverse datasets, integrated into physician workflows, and governed through transparent quality systems. AI can help reduce procedural variability, identify device alerts earlier, improve inventory planning, and accelerate product development through simulation and safety signal detection. However, industry leaders must manage algorithmic bias, cybersecurity, clinical validation, data privacy, and regulatory accountability to ensure AI-enabled cardiovascular implants deliver safe, effective, and equitable benefits.

Key Regional Insights Across Global Cardiovascular Implant Markets

Asia-Pacific is an increasingly important region for cardiovascular implants, supported by large patient populations, expanding hospital infrastructure, and rising adoption of interventional cardiology in China, India, Japan, South Korea, and Australia. Japan and Australia offer mature reimbursement systems and advanced procedural capabilities, while China and India continue to scale domestic manufacturing, public health coverage, and specialized cardiac centers to address the growing burden of ischemic heart disease, arrhythmias, valvular disorders, and heart failure.

North America remains a leading innovation and commercialization hub, driven by high procedure volumes, strong clinical trial networks, FDA-cleared technologies, and established reimbursement pathways in the United States and Canada. Europe combines sophisticated cardiovascular care with stricter evidence requirements under the Medical Device Regulation, creating an environment that rewards robust clinical data, post-market performance, and health technology assessment readiness. Latin America, led by Brazil and Mexico, is expanding access through private hospital networks and public procurement, although affordability, reimbursement fragmentation, and uneven specialist infrastructure remain constraints.

The Middle East is advancing through investment in tertiary care, medical tourism, and specialty cardiac programs, especially in Gulf economies with high rates of diabetes and cardiometabolic risk factors. Africa presents long-term opportunity as cardiovascular disease burdens rise and urban health systems expand, but near-term adoption is limited by lower specialist density, infrastructure gaps, and constrained reimbursement. Across all regions, local evidence generation, physician education, device servicing, and reliable distribution are decisive for sustainable cardiovascular implant adoption.

Key Group Insights for Cardiovascular Implants

ASEAN is gaining relevance as cardiovascular disease prevalence rises alongside urbanization, lifestyle risk factors, and population aging, with Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines showing varied levels of implant access, specialist density, and hospital capability. The GCC is distinguished by high healthcare spending, advanced hospital systems, and a strategic focus on cardiac centers of excellence, making it attractive for premium cardiovascular implants, remote monitoring, and digital follow-up models.

The European Union offers a large, regulated, and evidence-driven environment where clinical documentation, notified body capacity, and MDR compliance influence launch timelines and post-market obligations. BRICS economies represent a major adoption opportunity, with China, India, and Brazil combining large patient pools with growing domestic production, procurement sensitivity, and expanding interventional cardiology capacity. G7 countries remain central to premium innovation, clinical guideline development, and early adoption of complex implantable technologies, while NATO-aligned markets generally benefit from interoperable standards, resilient supply chain planning, and strong health system partnerships that support continuity of care for cardiovascular implant patients.

Key Country Insights in Cardiovascular Implants

The United States leads in cardiovascular implant innovation, clinical trials, and adoption of advanced rhythm management, structural heart, and vascular technologies, supported by specialized centers and established reimbursement. Canada emphasizes evidence-based adoption, provincial procurement, and quality-driven care pathways, while Mexico combines private-sector growth with cost-sensitive public demand. Brazil is Latin America’s largest healthcare market, supported by advanced cardiology centers, and continues to expand access despite reimbursement variability and regional disparities in specialist care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong cardiovascular procedure capacity, but procurement pressure and MDR-related evidence expectations influence product strategy. Germany is especially important for early clinical adoption and hospital-based innovation, while France and the United Kingdom emphasize health technology assessment, clinical utility, and reimbursement evidence. Russia remains a sizeable market where localization, supply continuity, and access considerations affect procurement and device availability.

China is scaling cardiovascular implant adoption through large hospital networks, domestic manufacturing, and volume-based procurement policies that intensify pricing and evidence requirements. India combines high cardiovascular disease burden with growing interventional cardiology capacity and strong price sensitivity, making affordability and physician training critical. Japan has a mature market with rigorous quality expectations and an aging population that supports demand for rhythm management and structural heart therapies. Australia benefits from high standards of care and reimbursement discipline, while South Korea is recognized for advanced hospitals, digital health readiness, and strong medical technology capabilities that support adoption of connected cardiovascular implant solutions.

Actionable Recommendations for Cardiovascular Implant Leaders

Industry leaders should prioritize differentiated clinical evidence, real-world performance data, and total cost-of-care outcomes to compete in an increasingly value-driven cardiovascular implants market. Organizations that demonstrate reduced complications, shorter hospital stays, longer device durability, improved remote monitoring, and better patient-reported outcomes will be better positioned with clinicians, payers, and procurement organizations.

Firms should also invest in AI-enabled workflow integration, cybersecurity, localized manufacturing or assembly where commercially justified, and physician training programs that support safe adoption. A region-specific strategy is essential: premium innovation can be prioritized in North America, Japan, Western Europe, Australia, South Korea, and the GCC, while affordability, service networks, distributor quality, and public procurement readiness are critical in China, India, Latin America, ASEAN, and Africa.

Research Methodology for Cardiovascular Implants Analysis

The research methodology combines secondary research from public health agencies, regulatory bodies, peer-reviewed literature, clinical trial registries, reimbursement references, hospital procedure indicators, and medical device safety communications with primary insights from industry participants where available. Sources such as the World Health Organization, national health agencies, U.S. FDA communications, European regulatory guidance, and recognized cardiovascular clinical societies provide the foundation for disease burden, regulatory, and technology trend assessment.

Findings are triangulated through cross-verification of epidemiology, procedure adoption, product approvals, regional reimbursement conditions, procurement trends, and competitive activity without relying on unsupported market claims. Qualitative interpretation is applied to assess strategic implications for manufacturers, healthcare providers, distributors, investors, and policy stakeholders in the cardiovascular implants ecosystem, with emphasis on verified, data-backed insights and exclusion of market sizing, market share, and forecasting statements.

Conclusion: Future Outlook for Cardiovascular Implants

The cardiovascular implants market is positioned for sustained strategic importance as health systems respond to the global burden of cardiovascular disease, aging demographics, and demand for less invasive care. Progress will not be determined by product availability alone; it will depend on evidence quality, procedural expertise, reimbursement alignment, device connectivity, supply reliability, and long-term patient outcomes.

Artificial intelligence, remote monitoring, advanced biomaterials, and transcatheter innovation are reshaping competition in cardiovascular implants. Organizations that combine clinically validated technologies with regional execution, regulatory excellence, and value-based evidence will be best positioned to capture opportunity across mature and emerging cardiovascular implant markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cardiovascular Implants Market, by Product Type
7.1. Introduction
7.2. Heart Valves
7.2.1. Mechanical
7.2.2. Tissue
7.2.2.1. Bovine
7.2.2.2. Equine
7.2.2.3. Porcine
7.3. Implantable Cardioverter Defibrillators
7.3.1. Dual Chamber
7.3.2. Single Chamber
7.4. Occluders
7.4.1. Atrial Septal Defect
7.4.2. Patent Foramen Ovale
7.5. Pacemakers
7.5.1. Biventricular
7.5.2. Dual Chamber
7.5.3. Single Chamber
7.6. Stents
7.7. Vascular Grafts
7.7.1. Biological
7.7.1.1. Allograft
7.7.1.2. Autograft
7.7.1.3. Xenograft
7.7.2. Synthetic
8. Cardiovascular Implants Market, by Material
8.1. Introduction
8.2. Biological Tissue
8.3. Metal
8.4. Polymer
9. Cardiovascular Implants Market, by Technology
9.1. Introduction
9.2. Bare Metal
9.3. Bioabsorbable
9.4. Drug Eluting
10. Cardiovascular Implants Market, by Procedure Invasiveness
10.1. Introduction
10.2. Minimally Invasive Implants
10.3. Open Surgical Implants
11. Cardiovascular Implants Market, by Application
11.1. Introduction
11.2. Acute Myocardial Infarction
11.3. Arrhythmias
11.4. Heart Failure
11.5. Myocardial Ischemia
11.6. Valvular Heart Disease
12. Cardiovascular Implants Market, by End-User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Hospitals
12.4. Specialty Clinics
13. Cardiovascular Implants Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Cardiovascular Implants Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cardiovascular Implants Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Abiomed, Inc.
17.3. Acandis GmbH
17.4. Artivion, Inc.
17.5. B. Braun Melsungen AG
17.6. Berlin Heart GmbH
17.7. Biosensors International Group, Ltd.
17.8. Biotronik SE & Co. KG
17.9. BiVACOR Inc.
17.10. Boston Scientific Corporation
17.11. CARMAT S.A.
17.12. Cook Medical LLC
17.13. Cordis Corporation
17.14. Edwards Lifesciences Corporation
17.15. Getinge AB
17.16. Integer Holdings Corporation
17.17. Jarvik Heart, Inc.
17.18. JOTEC GmbH
17.19. Lepu Medical Technology (Beijing) Co., Ltd.
17.20. LivaNova PLC
17.21. Medtronic plc
17.22. Meril Life Sciences Pvt. Ltd.
17.23. MicroPort Scientific Corporation
17.24. ReliantHeart Inc.
17.25. SynCardia Systems, LLC
17.26. Teleflex Incorporated
17.27. Terumo Corporation
17.28. Translumina GmbH
17.29. Vascular Concepts Limited
17.30. W. L. Gore & Associates, Inc.
List of Figures
FIGURE 1. GLOBAL CARDIOVASCULAR IMPLANTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CARDIOVASCULAR IMPLANTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL HEART VALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL HEART VALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL HEART VALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL MECHANICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL MECHANICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL MECHANICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL BOVINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL BOVINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL BOVINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL EQUINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL EQUINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL EQUINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PORCINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PORCINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PORCINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL DUAL CHAMBER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL DUAL CHAMBER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL DUAL CHAMBER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SINGLE CHAMBER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SINGLE CHAMBER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SINGLE CHAMBER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL OCCLUDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL OCCLUDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL OCCLUDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PATENT FORAMEN OVALE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PATENT FORAMEN OVALE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PATENT FORAMEN OVALE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL PACEMAKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL PACEMAKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL PACEMAKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL BIVENTRICULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BIVENTRICULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BIVENTRICULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DUAL CHAMBER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DUAL CHAMBER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DUAL CHAMBER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SINGLE CHAMBER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SINGLE CHAMBER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SINGLE CHAMBER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ALLOGRAFT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ALLOGRAFT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ALLOGRAFT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL AUTOGRAFT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL AUTOGRAFT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL AUTOGRAFT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL XENOGRAFT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL XENOGRAFT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL XENOGRAFT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICAL TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICAL TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICAL TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL METAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL METAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL METAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL POLYMER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL POLYMER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL POLYMER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL BARE METAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL BARE METAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL BARE METAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL BIOABSORBABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BIOABSORBABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL BIOABSORBABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DRUG ELUTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL DRUG ELUTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL DRUG ELUTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL MINIMALLY INVASIVE IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL MINIMALLY INVASIVE IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL MINIMALLY INVASIVE IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL OPEN SURGICAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL OPEN SURGICAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL OPEN SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ACUTE MYOCARDIAL INFARCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ACUTE MYOCARDIAL INFARCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ACUTE MYOCARDIAL INFARCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ARRHYTHMIAS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ARRHYTHMIAS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ARRHYTHMIAS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL HEART FAILURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL HEART FAILURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL HEART FAILURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL MYOCARDIAL ISCHEMIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL MYOCARDIAL ISCHEMIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL MYOCARDIAL ISCHEMIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 153. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 154. NORTH AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 169. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 171. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 172. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 173. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 174. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 175. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 176. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 177. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 178. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 179. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 180. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 181. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 182. EUROPE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 197. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 198. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 199. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 200. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 201. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 202. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 203. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 204. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 205. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 206. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 207. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 208. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 209. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 210. AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 211. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 213. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 214. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 215. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 216. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 217. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 218. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 219. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 220. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 221. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 222. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 223. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 224. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 225. ASEAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 226. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 227. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 228. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 229. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 230. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 231. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 232. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 233. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 234. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 235. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 236. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 237. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 238. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. GCC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 254. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 255. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 257. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 258. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 259. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 260. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 261. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 262. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 263. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 264. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 265. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 266. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 267. BRICS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 268. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 269. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 270. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 271. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 272. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 273. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 274. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 275. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 276. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 277. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 278. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 279. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 280. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 281. G7 CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 282. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 283. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 284. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 285. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 286. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 287. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 288. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 289. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 290. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 291. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 292. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 293. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 294. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 295. NATO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 296. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 299. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 300. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 301. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 303. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 305. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 306. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 307. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 308. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 309. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 310. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 311. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 313. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 314. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 315. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 316. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 317. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 318. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 319. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 320. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 321. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 322. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 323. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 324. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 325. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 327. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 328. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 329. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 330. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 331. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 332. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 333. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 334. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 335. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 336. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 337. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 338. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 339. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 340. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 341. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 342. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 343. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2017-2032 (USD MILLION)
TABLE 344. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2017-2032 (USD MILLION)
TABLE 345. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2017-2032 (USD MILLION)
TABLE 346. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 347. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 348. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 349. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 350. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PROCEDURE INVASIVENESS, 2017-2032 (USD MILLION)
TABLE 351. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 352. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 353. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 354. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 355. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2017-2032 (USD MILLION)
TABLE 356. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2017-2032 (USD MILLION)
TABLE 357. UNITED K

Companies Mentioned

  • Abbott Laboratories
  • Abiomed, Inc.
  • Acandis GmbH
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • Berlin Heart GmbH
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • BiVACOR Inc.
  • Boston Scientific Corporation
  • CARMAT S.A.
  • Cook Medical LLC
  • Cordis Corporation
  • Edwards Lifesciences Corporation
  • Getinge AB
  • Integer Holdings Corporation
  • Jarvik Heart, Inc.
  • JOTEC GmbH
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • ReliantHeart Inc.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Corporation
  • Translumina GmbH
  • Vascular Concepts Limited
  • W. L. Gore & Associates, Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 39.78 Billion
Forecasted Market Value ( USD ) by 2032 $ 57.98 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Cardiovascular Implants Market Report 2026 - Product Image

Cardiovascular Implants Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2026-2034 - Product Image

Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2026-2034

  • Report
  • 139 Pages
  • Global
From
Cardiovascular Implants Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Cardiovascular Implants Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Cardiovascular Implants - Global Strategic Business Report - Product Image

Cardiovascular Implants - Global Strategic Business Report

  • Report
  • 188 Pages
  • Global
From
Next Generation Implants Market Outlook 2026-2034: Market Share and Growth Analysis by Application (Orthopedic Implants, Cardiovascular Implants, Ocular Implants, Dental Implants, Other Applications), Material, End User - Product Image

Next Generation Implants Market Outlook 2026-2034: Market Share and Growth Analysis by Application (Orthopedic Implants, Cardiovascular Implants, Ocular Implants, Dental Implants, Other Applications), Material, End User

  • Report
  • 160 Pages
  • Global
From

About the Market

The Cardiovascular Implant market is a subset of the Cardiovascular Devices market, which includes a wide range of products used to diagnose, treat, and monitor cardiovascular diseases. Cardiovascular Implants are medical devices that are surgically implanted into the body to treat cardiovascular diseases. These devices include pacemakers, implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs). They are designed to regulate the heart rate, detect arrhythmias, and provide mechanical support to the heart. Cardiovascular Implants are used to treat a variety of cardiovascular diseases, including arrhythmias, heart failure, and coronary artery disease. They are also used to improve the quality of life of patients with cardiovascular diseases. Some of the major companies in the Cardiovascular Implant market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Sorin Group. These companies are involved in the development, manufacturing, and marketing of cardiovascular implants. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.